キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/11/04 | 876 | 877 | 785 | 803 | -70 | -8% | 641,900 |
| 2025/10/31 | 855 | 879 | 855 | 873 | +20 | +2.3% | 214,500 |
| 2025/10/30 | 856 | 871 | 850 | 853 | -6 | -0.7% | 207,400 |
| 2025/10/29 | 866 | 867 | 842 | 859 | +9 | +1.1% | 379,700 |
| 2025/10/28 | 867 | 882 | 847 | 850 | -15 | -1.7% | 431,600 |
| 2025/10/27 | 937 | 972 | 843 | 865 | -143 | -14.2% | 1,509,000 |
| 2025/10/24 | 1,011 | 1,019 | 999 | 1,008 | -1 | -0.1% | 162,800 |
| 2025/10/23 | 1,024 | 1,032 | 1,009 | 1,009 | -29 | -2.8% | 150,400 |
| 2025/10/22 | 1,031 | 1,046 | 1,029 | 1,038 | +4 | +0.4% | 132,000 |
| 2025/10/21 | 1,039 | 1,047 | 1,025 | 1,034 | -6 | -0.6% | 159,300 |
| 2025/10/20 | 1,014 | 1,046 | 1,005 | 1,040 | +41 | +4.1% | 192,500 |
| 2025/10/17 | 1,034 | 1,043 | 991 | 999 | -40 | -3.8% | 369,800 |
| 2025/10/16 | 1,032 | 1,052 | 1,032 | 1,039 | +7 | +0.7% | 181,900 |
| 2025/10/15 | 1,019 | 1,042 | 1,019 | 1,032 | +13 | +1.3% | 150,500 |
| 2025/10/14 | 1,026 | 1,044 | 1,003 | 1,019 | -45 | -4.2% | 441,900 |
| 2025/10/10 | 1,066 | 1,106 | 1,047 | 1,064 | +28 | +2.7% | 519,100 |
| 2025/10/09 | 1,048 | 1,060 | 1,024 | 1,036 | -10 | -1% | 219,600 |
| 2025/10/08 | 1,060 | 1,087 | 1,046 | 1,046 | -15 | -1.4% | 246,500 |
| 2025/10/07 | 1,082 | 1,109 | 1,052 | 1,061 | +9 | +0.9% | 523,800 |
| 2025/10/06 | 1,047 | 1,059 | 1,033 | 1,052 | +15 | +1.4% | 198,700 |
| 2025/10/03 | 1,035 | 1,065 | 1,035 | 1,037 | -7 | -0.7% | 234,700 |
| 2025/10/02 | 1,041 | 1,063 | 1,031 | 1,044 | +5 | +0.5% | 235,400 |
| 2025/10/01 | 1,058 | 1,069 | 1,036 | 1,039 | -49 | -4.5% | 331,300 |
| 2025/09/30 | 1,122 | 1,122 | 1,031 | 1,088 | -41 | -3.6% | 504,900 |
| 2025/09/29 | 1,178 | 1,183 | 1,121 | 1,129 | -46 | -3.9% | 452,900 |
| 2025/09/26 | 1,180 | 1,215 | 1,174 | 1,175 | -16 | -1.3% | 205,700 |
| 2025/09/25 | 1,180 | 1,218 | 1,165 | 1,191 | +16 | +1.4% | 254,800 |
| 2025/09/24 | 1,232 | 1,237 | 1,172 | 1,175 | -49 | -4% | 348,600 |
| 2025/09/22 | 1,282 | 1,302 | 1,214 | 1,224 | -68 | -5.3% | 416,300 |
| 2025/09/19 | 1,230 | 1,317 | 1,230 | 1,292 | +48 | +3.9% | 555,000 |
| 2025/09/18 | 1,195 | 1,261 | 1,195 | 1,244 | +42 | +3.5% | 301,700 |
| 2025/09/17 | 1,204 | 1,223 | 1,192 | 1,202 | -2 | -0.2% | 174,600 |
| 2025/09/16 | 1,204 | 1,219 | 1,133 | 1,204 | -28 | -2.3% | 391,500 |
| 2025/09/12 | 1,197 | 1,240 | 1,159 | 1,232 | +61 | +5.2% | 447,200 |
| 2025/09/11 | 1,174 | 1,184 | 1,155 | 1,171 | -8 | -0.7% | 230,900 |
| 2025/09/10 | 1,165 | 1,198 | 1,136 | 1,179 | +52 | +4.6% | 493,900 |
| 2025/09/09 | 1,200 | 1,225 | 1,100 | 1,127 | -78 | -6.5% | 948,400 |
| 2025/09/08 | 1,190 | 1,239 | 1,184 | 1,205 | -9 | -0.7% | 383,100 |
| 2025/09/05 | 1,196 | 1,220 | 1,185 | 1,214 | +18 | +1.5% | 343,800 |
| 2025/09/04 | 1,272 | 1,274 | 1,182 | 1,196 | -66 | -5.2% | 626,300 |
| 2025/09/03 | 1,352 | 1,375 | 1,251 | 1,262 | -109 | -8% | 698,200 |
| 2025/09/02 | 1,368 | 1,416 | 1,333 | 1,371 | +3 | +0.2% | 731,700 |
| 2025/09/01 | 1,270 | 1,408 | 1,266 | 1,368 | +68 | +5.2% | 899,200 |
| 2025/08/29 | 1,247 | 1,335 | 1,200 | 1,300 | +83 | +6.8% | 1,128,800 |
| 2025/08/28 | 1,356 | 1,378 | 1,167 | 1,217 | -163 | -11.8% | 2,060,100 |
| 2025/08/27 | 1,471 | 1,505 | 1,358 | 1,380 | -71 | -4.9% | 1,688,200 |
| 2025/08/26 | 1,368 | 1,558 | 1,339 | 1,451 | +102 | +7.6% | 2,882,000 |
| 2025/08/25 | 1,275 | 1,394 | 1,244 | 1,349 | -50 | -3.6% | 1,991,100 |
| 2025/08/22 | 1,221 | 1,399 | 1,204 | 1,399 | +202 | +16.9% | 4,542,400 |
| 2025/08/21 | 1,041 | 1,341 | 1,027 | 1,197 | +155 | +14.9% | 6,580,000 |
1～
50
件表示中 / 3816件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 80,300円 | - | - | 0.00% | - | 5.44倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| オンコリス | 76,500円 | +3771.0% | - | 0.00% | - | 13.82倍 |
|
腫瘍溶解ウイルス食道がん治療薬「テロメライシン」開発が柱。導出神経難病薬は米国治験中 |
| ステムリム | 27,300円 | - | - | 0.00% | - | 2.89倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 27,500円 | +0.1% | -70.9% | 0.00% | 30.69倍 | 1.74倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ラクオリア | 52,800円 | +25.1% | - | 0.00% | - | 2.07倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム
